Kellerhals Carrard advised Swiss clinical-stage biotechnology company MoonLake Immunotherapeutics on a debt funding deal with American venture lending specialist Hercules Capital, which was instead represented by Schellenberg Wittmer, acting as Swiss legal counsel. The deal
Tags :cn2
Kellerhals Carrard advised Burgdorf-based TecMed as lead counsel on the company’s acquisition of Ypsomed’s diabetes care business for CHF 420 million, including earn-out. Moreover, Walder Wyss represented the selling part throughout the transaction. Closing
Kellerhals Carrard advised the selling part in the sale of all the shares in Senn Chemicals to Granules India. Moreover, Loyens & Loeff represented Granules India throughout the operation. The parties signed the deal in
French automotive distributor BPM completed the acquisition of Renens-based Groupe Leuba. In connection with the deal, Borel & Barbey represented the buyer, while Kellerhals Carrard advised the shareholders of Groupe Leuba. The parties Headquartered in
Kellerhals Carrard advised Bloom Biorenewables in connection with the closing of its CHF 13M Series A financing round. The investors Anaïs Ventures and Valquest Partners led the capital round in question, with further participation
Kellerhals Carrard advised outplacement consultancy firm Von Rundstedt Switzerland on becoming part of the Alixio Group as well as integrating the OTP Group. The operations lead to an expansion of Von Rundstedt’s services toward
Kellerhals Carrard advised AI transformation company Vector8 on acquisition of Swiss AI company aighty-twenty and strategic consultancy firm Morrow. The parties Founded in 2024 and operating across Europe with over 50 full-time employees, vector8’s AI focus
Kellerhals Carrard advised Swiss startup Food Brewer on all legal aspects of their recent extended seed funding round. The context Headquartered in Zurich, Food Brewer produces and sells cocoa and coffee alternatives. The company also
Lenz & Staehelin is advising both parties in connection with the continuation fund aimed at extending JLL Partners’ investment in Solvias. The operation originated through an older JLL Partners fund who acquired Solvias in 2020 alongside
Lenz & Staehelin advised South-Korean SK Telecom on all Swiss law aspects of its strategic partnership agreement with US-based quantum computing company, IonQ. The deal SK Telecom has agreed to transfer all its shares in
